# BioTissue Holdings Inc – FDA Inspection, Feb 6, 2018

Source: https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/adf9e664-a7c0-4ef7-a540-5973fcb81967
Source feed: FDA_Inspections

> FDA inspection 1040962 of BioTissue Holdings Inc, February 06, 2018. Classification: Voluntary Action Indicated (VAI). 11 citations under 21 CFR part 1271. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040962
- Company Name: BioTissue Holdings Inc
- Inspection Date: 2018-02-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 11

## Related Documents

- [FDA Inspection 1312222 - 2026-09-01](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/2f1713bf-8719-4236-8d5b-c9006f742ec8)
- [FDA Inspection 1304322 - 2026-02-18](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/521aafa6-8d2b-423e-89e1-46e5342a5736)
- [FDA Inspection 1230477 - 2024-03-06](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/bb637f4d-fcd0-472a-a159-54470476dd42)
- FDA Inspection 1101487 - 2019-08-15
- [FDA Inspection 1096403 - 2019-07-16](https://www.keypedia.com/records/fda_inspections/biotissue-holdings-inc/bf4d02a7-4b2b-49b5-a551-f9dac05d4348)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/shavon-l-square/6a15df34-1af6-44f7-8874-c8606691f7e0)

Company: https://www.keypedia.com/companies/biotissue-holdings-inc/2cac95ce-8ef8-451a-aa9d-4d03238d18d8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d